Related Experiment Video
Updated: Nov 26, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Long-term exposure of human endothelial cells to metformin modulates miRNAs and isomiRs
Angelica Giuliani1, Eric Londin2, Manuela Ferracin3
1Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Via Tronto 10/A, 60126, Ancona, Italy.
Abstract:
Increasing evidence suggest that the glucose-lowering drug metformin exerts a valuable anti-senescence role. The ability of metformin to affect the biogenesis of selected microRNAs (miRNAs) was recently suggested. MicroRNA isoforms (isomiRs) are distinct variations of miRNA sequences, harboring addition or deletion of one or more nucleotides at the 5' and/or 3' ends of the canonical miRNA sequence. We performed a comprehensive analysis of miRNA and isomiR profile in human endothelial cells undergoing replicative senescence in presence of metformin. Metformin treatment was associated with the differential expression of 27 miRNAs (including miR-100-5p, -125b-5p, -654-3p, -217 and -216a-3p/5p). IsomiR analysis revealed that almost 40% of the total miRNA pool was composed by non-canonical sequences. Metformin significantly affects the relative abundance of 133 isomiRs, including the non-canonical forms of the aforementioned miRNAs. Pathway enrichment analysis suggested that pathways associated with proliferation and nutrient sensing are modulated by metformin-regulated miRNAs and that some of the regulated isomiRs (e.g. the 5' miR-217 isomiR) are endowed with alternative seed sequences and share less than half of the predicted targets with the canonical form. Our results show that metformin reshapes the senescence-associated miRNA/isomiR patterns of endothelial cells, thus expanding our insight into the cell senescence molecular machinery.
Insights
Metformin, a diabetes drug, alters microRNA (miRNA) and microRNA isoform (isomiR) patterns in aging human endothelial cells. This reshaping of miRNA/isomiR profiles offers new insights into cellular senescence.
Area of Science:
- Cell Biology
- Molecular Biology
- Gerontology
Background:
- Metformin, a widely used glucose-lowering medication, is increasingly recognized for its anti-senescence properties.
- Emerging research suggests metformin influences microRNA (miRNA) biogenesis.
- MicroRNA isoforms (isomiRs) represent sequence variations of canonical miRNAs, potentially altering their function.
Purpose of the Study:
- To comprehensively analyze the impact of metformin on miRNA and isomiR profiles in human endothelial cells experiencing replicative senescence.
- To investigate how metformin modulates the expression and relative abundance of specific miRNAs and their isoforms during cellular aging.
Main Methods:
- Analysis of miRNA and isomiR profiles in human endothelial cells treated with metformin during replicative senescence.
- Differential expression analysis of miRNAs and isomiRs.
- Pathway enrichment analysis to identify biological processes affected by metformin-regulated miRNAs and isomiRs.
Main Results:
- Metformin treatment led to differential expression of 27 miRNAs, including notable examples like miR-100-5p and miR-217.
- IsomiR analysis revealed that non-canonical sequences constitute a significant portion (nearly 40%) of the miRNA pool.
- Metformin significantly altered the relative abundance of 133 isomiRs, including non-canonical forms of key miRNAs. Some isomiRs exhibited alternative seed sequences and distinct target profiles compared to canonical forms.
- Pathway analysis indicated that metformin modulates pathways related to proliferation and nutrient sensing via regulated miRNAs.
Conclusions:
- Metformin significantly reshapes the senescence-associated miRNA and isomiR landscape in endothelial cells.
- The study expands the understanding of the molecular mechanisms underlying metformin's anti-senescence effects.
- The findings highlight the importance of considering isomiRs in miRNA-mediated drug actions and cellular processes like senescence.
Related Concept Videos
MicroRNAs
MicroRNAs
Oral Hypoglycemic Agents: Biguanides and Glitazones

